Hydralyte International (ASX:HPC)

Hydralyte International: Leveraging a Rapidly Expanding Hydration Market in North America


Hydralyte International (ASX:HPC) is a rapid hydration solutions business with a solid manufacturing base and supply chain focused on the large North American and European markets. The company recently surpassed US$10.4 million in 12-month trailing revenue with a gross margin of a staggering 58 percent during Q3 FY23 delivering strong revenue of US$2.6 million in Q3 2023.

Hydralyte rapid rehydration product was also the number one SKU in the hydration category on Amazon Prime Day in Canada. Hydralyte delivered ~US$140,000 in gross sales over 48 hours – which has underpinned a strong ecommerce sales pipeline in the recent months.

Hydralyte International

Hydralyte is available in three forms: ready-to-drink, tablet and dissolvable powder stick. All three are widely accepted in the medical community. Hydralyte is also frequently used by professional athletes as an alternative to sports drinks.

Made from all-natural ingredients, it contains the precise ratio of glucose and electrolytes necessary to rehydrate. Its innovative formula contains up to 75 percent less sugar and four times more electrolytes than the majority of sports drinks.

Company Highlights

  • Hydralyte International is a rapid hydration drink business with a focus on North America and established supply chains in both the United States and Canada.
  • The company's 2023 financials are incredibly promising:
    • Trailing 12 months revenue of US$10.4 million in Q3 FY23
    • 58 percent gross margin in Q3 2023
    • Cash burn reduction of 47 percent on PCP to US$1.46 million in Q3 FY22, with initiatives in place expected to reduce this further
    • US$140,000 in gross sales from Amazon Prime Day in July.
  • Although Hydralyte recently reduced its marketing expenditure, it still experienced strong revenue growth throughout the first three quarters of 2023, driven by ongoing eCommerce sales, an established brick-and-mortar footprint, new SKU additions and a partnership with leading entrepreneur and actress, Shay Mitchell.
  • The United Kingdom represents an international expansion opportunity for Hydralyte, with products being sold on Amazon UK and appearing on store shelves in Whole Foods and Chemist Warehouse.
  • Agreement with specialist e-commerce company RooLife Group Limited (ASX: RLG) to exclusively market, sell and distribute Hydralyte products in China
  • Appointed leading health and wellness products broker LeBeau Excel as its new sales broker, giving Hydralyte the ability to significantly expand its footprint in the Canadian market.
  • In addition to a solid manufacturing base and supply chain, Hydralyte is supported by leaders with decades of experience in health and wellness.
  • Hydralyte products are widely accepted in both the medical and athletic communities. As a result, the company is extremely well-positioned to leverage the fast-growing electrolyte hydration drinks market.

This Hydralyte International profile is part of a paid investor education campaign.*

Click here to connect with Hydralyte International (ASX:HPC) to receive an Investor Presentation

HPC:AU
Hydralyte International

Hydralyte International Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
Hydralyte International (ASX:HPC)

Hydralyte International


Keep reading...Show less

AMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION

James Bradner , M.D., Joins as Executive Vice President, Research and Development, and Chief Scientific Officer

David M. Reese, M.D., Named Executive Vice President and Chief Technology Officer

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

AMGEN TO SPONSOR THE IRISH OPEN

Sponsorship of the Golf Event Continues Following Horizon Acquisition

Golfers Shane Lowry , Pádraig Harrington, Séamus Power and Brendan Lawlor Will Become Amgen Golf Ambassadors

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer

Currently There are no Approved Therapeutic Options for Third-Line Treatment of Advanced SCLC 1

If Approved, Tarlatamab Would be the First BiTE ® Therapy for a Major Solid Tumor

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
row of test tubes and pipette with chemical droplet chemical coming from it

Top 5 NASDAQ Biotech Stocks of 2023

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has slowly tracked downward over the course of 2023 in response to the high levels of volatility seen across global markets.

Starting out the year at 4,174.3, the index was at 3,998.54 as of December 6, 2023. But while the current economic environment means the biotech sector may have a complex road ahead, robust growth could be in store in the future.

According to a recent report from Grand View Research, the global biotech market is expected to grow at a compound annual growth rate of 13.96 percent from now to 2030, reaching a valuation of US$3.88 trillion.

Keep reading...Show less

AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the first quarter of 2024. This is the 12th consecutive year that Amgen has increased its dividend and comes as the Company continues to invest in innovation and deleverage its balance sheet. The dividend will be paid on March 7, 2024 to all stockholders of record as of the close of business on February 16, 2024 .

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
two people drinking different coloured beverages out of water bottles

Consumer Trends Shaping Functional Beverage Market and Presenting Investment Opportunities

Sustainability has been a major selling point for consumer brands in recent years, but most recently, sophisticated customers are paying more attention to how the products impact their health, as well as the environment.

This shift in behaviour has created significant growth across multiple markets and had a considerable impact on the functional beverage sector.

This shift has also unlocked a number of significant investment opportunities in the functional beverage market, but identifying them requires a deeper understanding of the market's core drivers.

Keep reading...Show less
Hydralyte International

Hydralyte International Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Related News

×